Arizona 57th Legislature - Second Regular Session Status: Passed House 2 R cosponsors

HB 2444 — pharmacists; independent testing; treatment

Last action — DPA

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 57th Legislature - Second Regular Session. It reached “Passed House” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there are no live odds of enactment. It would have to be reintroduced in the current session to move again.

Bill Text

What changed in the latest version

208 added · 158 removed

Plain-language change summary

The bill HB 2444 has been updated to allow pharmacists to independently order and conduct tests and treatments for certain health conditions without needing a doctor's prior approval. Notably, the eligibility age for patients has changed from six years to twelve years or older. Additionally, the provision for treating specific viruses, including SARS-CoV-2, has been removed. These changes aim to enhance pharmacists' roles in healthcare, making it easier for older patients to receive timely treatment for common illnesses like influenza and strep throat.

→
Previous
Latest
Fifty-seventh Legislature Health & Human Services Second Regular Session H.B.
House Engrossed pharmacists;
2444 PROPOSED HOUSE OF REPRESENTATIVES AMENDMENTS TO H.B.
independent testing;
2444 (Reference to printed bill) Amendment instruction key:
treatment State of Arizona House of Representatives Fifty-seventh Legislature Second Regular Session HOUSE BILL 2444 AN ACT AMENDING TITLE 32, CHAPTER 18, ARTICLE 3, ARIZONA REVISED STATUTES, BY ADDING SECTIONS 32-1979.04, 32-1979.05 AND 32-1979.06;
[GREEN UNDERLINING IN BRACKETS] indicates text added to statute or previously enacted session law.
RELATING TO THE ARIZONA STATE BOARD OF PHARMACY.
[Green underlining in brackets] indicates text added to new session law or text restoring existing law.
(TEXT OF BILL BEGINS ON NEXT PAGE) - i - H.B.
[GREEN STRIKEOUT IN BRACKETS] indicates new text removed from statute or previously enacted session law.
2444 Be it enacted by the Legislature of the State of Arizona:
[Green strikeout in brackets] indicates text removed from existing statute, previously enacted session law or new session law.
<<Green carets>> indicate a section added to the bill.
<<Green strikeout in carets>> indicates a section removed from the bill.
The bill as proposed to be amended is reprinted as follows:
Title 32, chapter 18, article 3, Arizona Revised Statutes, is amended by adding section 32-1979.04, to read:
Title 32, chapter 18, article 3, Arizona Revised Statutes, is amended by adding sections 32-1979.04, 32-1979.05 and 32-1979.06, to read:
notification requirements A.
notification and insurance requirements A.
A PHARMACIST MAY INDEPENDENTLY INITIATE TREATMENT TO ELIGIBLE PERSONS WHO ARE AT LEAST [SIX] [TEN] YEARS OF AGE OR THE AGE AUTHORIZED BY THE TREATMENT, WHICHEVER AGE IS OLDER, AND WHO HAVE TEST RESULTS THAT INDICATE THE NEED FOR TREATMENT, BY A TEST THAT IS AUTHORIZED BY THE UNITED STATES FOOD AND DRUG ADMINISTRATION AND WAIVED UNDER THE CLINICAL LABORATORY IMPROVEMENT AMENDMENTS OF 1988, FOR ANY OF THE FOLLOWING:
A PHARMACIST MAY INDEPENDENTLY INITIATE TREATMENT TO ELIGIBLE PERSONS WHO ARE AT LEAST TWELVE YEARS OF AGE OR THE AGE AUTHORIZED BY THE TREATMENT, WHICHEVER AGE IS OLDER, AND WHO HAVE TEST RESULTS THAT INDICATE THE NEED FOR TREATMENT, BY A TEST THAT IS AUTHORIZED BY THE UNITED STATES FOOD AND DRUG ADMINISTRATION AND WAIVED UNDER THE CLINICAL LABORATORY IMPROVEMENT AMENDMENTS OF 1988, FOR ANY OF THE FOLLOWING:
[4.
4.
HUMAN IMMUNODEFICIENCY VIRUS PREEXPOSURE PROPHYLAXIS OR POSTEXPOSURE PROPHYLAXIS.] [5.] [4.] A CONDITION RELATED TO AN EMERGING OR EXISTING PUBLIC HEALTH THREAT IDENTIFIED BY THE DEPARTMENT OF HEALTH SERVICES FOR WHICH A STATEWIDE STANDING ORDER, RULE OR EXECUTIVE ORDER IS ISSUED.
A CONDITION RELATED TO AN EMERGING OR EXISTING PUBLIC HEALTH THREAT IDENTIFIED BY THE DEPARTMENT OF HEALTH SERVICES FOR WHICH A STATEWIDE STANDING ORDER, RULE OR EXECUTIVE ORDER IS ISSUED.
House Amendments to H.B.
2.
2444 2.
ANY NECESSARY PHARMACIST TRAINING OR CERTIFICATION REQUIREMENTS.
PHARMACIST TRAINING AND CERTIFICATION REQUIREMENTS.
D.
- 1 - H.B.
A PHARMACIST SHALL USE EVIDENCE-BASED CLINICAL GUIDELINES PUBLISHED BY THE UNITED STATES CENTERS FOR DISEASE CONTROL AND PREVENTION OR THE INFECTIOUS DISEASES SOCIETY OF AMERICA, THE AMERICAN ACADEMY OF PEDIATRICS COMMITTEE ON INFECTIOUS DISEASE OR ANOTHER CLINICALLY RECOGNIZED RECOMMENDATION IN PROVIDING PATIENT TREATMENT PURSUANT TO SUBSECTION A OF THIS SECTION.
2444 D.
A PHARMACIST SHALL USE EVIDENCE-BASED CLINICAL GUIDELINES PUBLISHED BY THE UNITED STATES CENTERS FOR DISEASE CONTROL AND PREVENTION OR THE INFECTIOUS DISEASES SOCIETY OF AMERICA, THE AMERICAN ACADEMY OF PEDIATRICS COMMITTEE ON INFECTIOUS DISEASE OR ANOTHER CLINICALLY RECOGNIZED RECOMMENDATION THAT ALIGNS WITH STANDARDS OF CARE IN PROVIDING PATIENT TREATMENT PURSUANT TO SUBSECTION A OF THIS SECTION.
MAINTAIN A RECORD OF THE RESULTS OF ANY TESTING OR SCREENING FOR WHICH A TREATMENT IS INITIATED PURSUANT TO THIS SECTION, INCLUDING A SUMMARY OF THE VISIT AND PATIENT ASSESSMENT INFORMATION, FOR A PERIOD OF SEVEN YEARS.
MAINTAIN FOR AT LEAST SEVEN YEARS A RECORD OF THE RESULTS OF ANY TESTING OR SCREENING FOR WHICH A TREATMENT IS INITIATED PURSUANT TO THIS SECTION, INCLUDING A SUMMARY OF THE VISIT, PATIENT ASSESSMENT INFORMATION, HISTORY OF ILLNESS, EXAMINATION FINDINGS, VITALS AND PLAN OF CARE.
-2- House Amendments to H.B.
3.
2444 3.
A PHARMACIST MAY NOT DELEGATE ANY TASKS THAT INCLUDE CLINICAL JUDGMENT OR TREATMENT AND MAY DELEGATE ONLY ANCILLARY DUTIES AS ALLOWED BY BOARD RULES.
A PHARMACIST MAY NOT DELEGATE ANY TASKS THAT INCLUDE CLINICAL - 2 - H.B.
2444 JUDGMENT OR TREATMENT AND MAY DELEGATE ONLY ANCILLARY DUTIES AS ALLOWED BY BOARD RULES.
PURSUANT TO SECTION 32-1901.01, SUBSECTION A, PARAGRAPH 21, AN EMPLOYER MAY NOT OVERRULE A PHARMACIST'S DECISION TO NOT PROVIDE SERVICES THAT ARE AUTHORIZED BY THIS SECTION.
A PHARMACY SHALL EITHER DISPLAY A NOTICE OR INCLUDE IN A PATIENT'S CONSENT PAPERWORK THAT THE TESTING AND TREATMENT BEING PERFORMED PURSUANT TO THIS SECTION ARE BEING PERFORMED BY A PHARMACIST WITHOUT CONSULTATION WITH OR OVERSIGHT BY A PHYSICIAN AND THAT THE PATIENT SHOULD CONSULT WITH A PRIMARY CARE PROVIDER IF SYMPTOMS CONTINUE.
A PHARMACY SHALL DISPLAY A NOTICE AND INCLUDE IN A PATIENT'S CONSENT PAPERWORK THAT THE TESTING AND TREATMENT BEING PERFORMED PURSUANT TO THIS SECTION ARE BEING PERFORMED BY A PHARMACIST WITHOUT CONSULTATION WITH OR OVERSIGHT BY A PHYSICIAN AND THAT THE PATIENT SHOULD CONSULT WITH A PRIMARY CARE PROVIDER IF SYMPTOMS CONTINUE.
Sec.
N.
2.
A PHARMACIST SHALL MAINTAIN PROFESSIONAL LIABILITY INSURANCE IF PERFORMING SERVICES THAT ARE AUTHORIZED UNDER THIS SECTION.
32-1979.05.
members;
members A.
delayed repeal A.
THE BOARD SHALL ESTABLISH THE INDEPENDENT TESTING AND TREATMENT ADVISORY COMMITTEE TO ASSIST THE BOARD IN DEVELOPING THIS STATE'S WRITTEN PROTOCOLS RELATING TO PHARMACISTS' INDEPENDENT AUTHORITY TO ORDER TESTING AND INITIATE TREATMENTS PURSUANT TO SECTIONS 32-1979.04 AND 32-1979.06.
The Arizona state board of pharmacy shall convene an advisory committee to assist the board in developing this state's written protocols relating to pharmacists' independent authority to order testing and initiate treatments pursuant to section 32-1979.04, Arizona Revised Statutes, as added by this act.
THE ADVISORY COMMITTEE SHALL ALSO MAKE RECOMMENDATIONS TO THE BOARD REGARDING THE PROTOCOLS REQUIRED PURSUANT TO THAT SECTION.
The advisory committee shall also make recommendations to the Arizona state board of pharmacy regarding the protocols required pursuant to that section.
The advisory committee shall include at least the following:
THE ADVISORY COMMITTEE SHALL INCLUDE AT LEAST THE FOLLOWING:
Two pharmacists who are licensed pursuant to title 32, chapter 18, Arizona Revised Statutes, and who are appointed by the Arizona state board of pharmacy.
TWO PHARMACISTS WHO ARE LICENSED PURSUANT TO THIS CHAPTER AND WHO ARE APPOINTED BY THE BOARD.
-3- House Amendments to H.B.
2.
2444 2.
TWO PHYSICIANS WHO ARE LICENSED PURSUANT TO THIS TITLE, ONE WHO SPECIALIZES IN PRIMARY CARE AND ONE WHO PRACTICES IN AN EMERGENCY MEDICINE SETTING, AND WHO ARE APPOINTED BY THE ARIZONA MEDICAL BOARD OR THE ARIZONA BOARD OF OSTEOPATHIC EXAMINERS IN MEDICINE AND SURGERY.
Two physicians who are licensed pursuant to title 32, chapter 13 or 17, Arizona Revised Statutes, who specialize in primary care, at least one of whom has a patient population that is substantially composed of children and adolescents, and who are appointed by the Arizona medical board or the Arizona board of osteopathic examiners in medicine and surgery.
AT LEAST ONE OF THESE MEMBERS MUST HAVE A PATIENT POPULATION THAT IS SUBSTANTIALLY COMPOSED OF CHILDREN AND ADOLESCENTS.
Show all 93 changed rows (53 more)
Previous
Latest
One person who represents a nonprofit patient advocacy organization and who is appointed by the governor.
ONE PERSON WHO REPRESENTS A NONPROFIT PATIENT ADVOCACY ORGANIZATION AND WHO IS APPOINTED BY THE GOVERNOR.
One nurse practitioner who is licensed pursuant to title 32, chapter 15, Arizona Revised Statutes, who specializes in primary care and who is able to prescribe medication and who is appointed by the Arizona state board of nursing.
ONE NURSE PRACTITIONER WHO IS LICENSED PURSUANT TO CHAPTER 15 OF THIS TITLE, WHO SPECIALIZES IN PRIMARY CARE OR EMERGENCY MEDICINE, WHO IS ABLE TO PRESCRIBE MEDICATION AND WHO IS APPOINTED BY THE ARIZONA STATE BOARD OF NURSING.
- 3 - H.B.
2444 C.
ADVISORY COMMITTEE MEMBERS ARE NOT ELIGIBLE FOR COMPENSATION OR REIMBURSEMENT OF EXPENSES.
D.
THE ADVISORY COMMITTEE SHALL REVIEW THE STATEWIDE PROTOCOLS ANNUALLY AND UPDATE WHEN NECESSARY.
32-1979.06.
Human immunodeficiency virus prevention;
preexposure prophylaxis;
postexposure prophylaxis;
definitions A.
IN ADDITION TO THE AUTHORITY PROVIDED IN SECTION 32-1979.04, A PHARMACIST WHO IS LICENSED PURSUANT TO THIS CHAPTER MAY INITIATE AND DISPENSE HUMAN IMMUNODEFICIENCY VIRUS PREEXPOSURE PROPHYLAXIS AND POSTEXPOSURE PROPHYLAXIS PURSUANT TO THE STATEWIDE WRITTEN PROTOCOL APPROVED BY THE BOARD.
B.
BEFORE INITIATING A PREEXPOSURE PROPHYLAXIS, A PHARMACIST SHALL:
1.
CONDUCT OR OBTAIN A CLINICAL LABORATORY IMPROVEMENT AMENDMENTS-WAIVED HUMAN IMMUNODEFICIENCY VIRUS TEST AND CONFIRM A NEGATIVE TEST RESULT.
2.
ASSESS THE PATIENT FOR CONTRAINDICATIONS, DRUG INTERACTIONS AND CLINICAL ELIGIBILITY CONSISTENT WITH THE CURRENT GUIDELINES OF THE UNITED STATES CENTERS FOR DISEASE CONTROL AND PREVENTION.
Advisory committee members are not eligible for compensation or reimbursement of expenses.
BEFORE INITIATING A POSTEXPOSURE PROPHYLAXIS, A PHARMACIST SHALL:
1.
DETERMINE THAT THE PATIENT PRESENTS WITHIN SEVENTY-TWO HOURS AFTER A POTENTIAL EXPOSURE TO THE HUMAN IMMUNODEFICIENCY VIRUS.
2.
CONDUCT OR OBTAIN A HUMAN IMMUNODEFICIENCY VIRUS TEST IF FEASIBLE UNDER THE STATEWIDE WRITTEN PROTOCOL.
3.
ASSESS THE PATIENT FOR CONTRAINDICATIONS, DRUG INTERACTIONS AND CLINICAL ELIGIBILITY CONSISTENT WITH THE CURRENT GUIDELINES OF THE UNITED STATES CENTERS FOR DISEASE CONTROL AND PREVENTION.
This section is repealed from and after December 31, 2027.
A PHARMACIST WHO INITIATES THERAPY PURSUANT TO THIS SECTION:
Enroll and engross to conform Amend title to conform CHRIS LOPEZ 2444LOPEZ.docx 02/06/2026 05:18 PM C:
1.
MH 130JRWUUD -4-
MAY DISPENSE NOT MORE THAN A THIRTY-DAY SUPPLY OF PREEXPOSURE PROPHYLAXIS.
2.
MAY DISPENSE A COMPLETE TWENTY-EIGHT-DAY COURSE OF POSTEXPOSURE PROPHYLAXIS.
3.
SHALL PROVIDE COUNSELING REGARDING MEDICATION ADHERENCE, POTENTIAL SIDE EFFECTS AND PREVENTION MEASURES.
4.
SHALL PROVIDE THE PATIENT WITH A WRITTEN REFERRAL TO A PRIMARY CARE PROVIDER OR OTHER APPROPRIATE HEALTH CARE PROVIDER FOR FOLLOW-UP CARE.
5.
SHALL NOTIFY THE PATIENT'S PRIMARY CARE PROVIDER OF THE SERVICES PROVIDED IF THE PATIENT CONSENTS TO THE NOTIFICATION.
E.
THE STATEWIDE WRITTEN PROTOCOL APPROVED BY THE BOARD SHALL ADDRESS, AT A MINIMUM, THE FOLLOWING:
1.
MINIMUM TRAINING REQUIREMENTS FOR PHARMACISTS WHO INITIATE THERAPY PURSUANT TO THIS SECTION.
2.
DOCUMENTATION AND RECORDS RETENTION REQUIREMENTS.
- 4 - H.B.
2444 3.
STATEWIDE WRITTEN PROTOCOL STANDARDS THAT ARE CONSISTENT WITH THE CURRENT GUIDELINES OF THE UNITED STATES CENTERS FOR DISEASE CONTROL AND PREVENTION OR THE INFECTIOUS DISEASES SOCIETY OF AMERICA OR ANOTHER CLINICALLY RECOGNIZED RECOMMENDATION.
F.
FOR THE PURPOSES OF THIS SECTION:
1.
"POSTEXPOSURE PROPHYLAXIS" MEANS A MEDICATION REGIMEN THAT IS APPROVED BY THE UNITED STATES FOOD AND DRUG ADMINISTRATION AND THAT IS INITIATED AFTER POTENTIAL EXPOSURE TO THE HUMAN IMMUNODEFICIENCY VIRUS TO PREVENT INFECTION.
2.
"PREEXPOSURE PROPHYLAXIS" MEANS A MEDICATION REGIMEN THAT IS APPROVED BY THE UNITED STATES FOOD AND DRUG ADMINISTRATION TO PREVENT HUMAN IMMUNODEFICIENCY VIRUS INFECTION IN PERSONS WHO ARE AT RISK.
- 5 -
View plain text versions (5)

Action History

  1. DPA

  2. PASSED

  3. PASSED

  4. PASSED

  5. PASSED

  6. Transmit to Senate

  7. PASSED

  8. DPA

  9. DPA

  10. House Second Reading

  11. House First Reading.

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 1 co-sponsors · 91 not signed on · 21 voted No

Sponsors (1)

Co-sponsors (1)

Not signed on (91)

91 members have not signed on to this bill.

Show all 91 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Votes

Passed

Passed 33 Yea · 22 Nay · 4 Other
Party YeaNayPresentNot Voting
Democrat 19404
Republican 141801
Total 332205
% of votes cast 55%37%0%8%
How each member voted (60)
Member Party Vote
Aaron Márquez Democrat Nay
Alma Hernandez Democrat Yea
Anna Abeytia Democrat Not Voting
Betty J Villegas Democrat Yea
Brian Garcia Democrat Yea
Cesar Aguilar Democrat Yea
Christopher Mathis Democrat Yea
Consuelo Hernandez Democrat Yea
Elda Luna-Nájera Democrat Yea
Janeen Connolly Democrat Not Voting
Junelle Cavero Democrat Not Voting
Kevin Volk Democrat Yea
Lorena Austin Democrat Nay
Lupe Contreras Democrat Yea
Lydia Hernandez Democrat Yea
Mae Peshlakai Democrat Yea
Mariana Sandoval Democrat Nay
Myron Tsosie Democrat Yea
Nancy Gutierrez Democrat Yea
Oscar De Los Santos Democrat Yea
Patty Contreras Democrat Yea
Quantá Crews Democrat Yea
Sarah Liguori Democrat Nay
Seth Blattman Democrat Not Voting
Stacey Travers Democrat Yea
Stephanie Simacek Democrat Yea
Stephanie Stahl Hamilton Democrat Yea
Alexander Kolodin Republican Nay
Beverly Pingerelli Republican Nay
Chris Lopez Republican Yea
David Livingston Republican Yea
David Marshall, Sr. Republican Yea
Gail Griffin Republican Yea
James Taylor Republican Yea
Jeff Weninger Republican Yea
John Gillette Republican Nay
Joseph Chaplik Republican Not Voting
Julie Willoughby Republican Nay
Justin Olson Republican Nay
Justin Wilmeth Republican Nay
Khyl Powell Republican Nay
Laurin Hendrix Republican Nay
Leo Biasiucci Republican Nay
Lisa Fink Republican Nay
Lupe Diaz Republican Yea
Matt Gress Republican Nay
Michael Carbone Republican Nay
Michael Way Republican Nay
Michele Peña Republican Yea
Neal Carter Republican Nay
Nick Kupper Republican Nay
Pamela Carter Republican Nay
Quang H Nguyen Republican Yea
Rachel Keshel Republican Nay
Ralph Heap Republican Nay
Selina Bliss Republican Yea
Steve Montenegro Republican Yea
Teresa Martinez Republican Yea
Tony Rivero Republican Yea
Walt Blackman Republican Yea

Official roll call →

Subjects

Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

Who sponsors HB 2444?
HB 2444 is sponsored by Justin Wilmeth (Republican) and Chris Lopez (Republican).
What is the current status of HB 2444?
This bill died with 57th Legislature - Second Regular Session. It reached “Passed House” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track HB 2444?
Track HB 2444 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 2444

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Stay ahead of HB 2444

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →